<code id='72056A57B9'></code><style id='72056A57B9'></style>
    • <acronym id='72056A57B9'></acronym>
      <center id='72056A57B9'><center id='72056A57B9'><tfoot id='72056A57B9'></tfoot></center><abbr id='72056A57B9'><dir id='72056A57B9'><tfoot id='72056A57B9'></tfoot><noframes id='72056A57B9'>

    • <optgroup id='72056A57B9'><strike id='72056A57B9'><sup id='72056A57B9'></sup></strike><code id='72056A57B9'></code></optgroup>
        1. <b id='72056A57B9'><label id='72056A57B9'><select id='72056A57B9'><dt id='72056A57B9'><span id='72056A57B9'></span></dt></select></label></b><u id='72056A57B9'></u>
          <i id='72056A57B9'><strike id='72056A57B9'><tt id='72056A57B9'><pre id='72056A57B9'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:hotspot    Page View:6
          Photo of a doctor holding a cellphone. -- first opinion coverage from STAT
          Adobe

          Thinking about messaging your physician about a weird rash? You may want to hold off on it. Some hospital systems have started charging patients for digital messages to their doctors via the electronic medical record, either a flat rate (like a copay) or on sliding scale depending on the time or complexity of the physician’s response. Sometimes it’s billed through an insurer, sometimes as a direct cost to the patient. Costs have ranged between less than $10 and $100 for a message.

          Now that at least 22 hospital systems have implemented the practice, a great debate has broken out in the medical profession: Is charging patients to send a note to a doctor just common sense or an unjust expense?

          advertisement

          In asking family, friends, and colleagues about this, my grandmother’s response was the most enlightening: “I’m surprised doctors ever stopped charging for phone calls!”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          FDA panel to weigh approval of NurOwn, controversial ALS drug
          FDA panel to weigh approval of NurOwn, controversial ALS drug

          AdobeYearsofpolarizingscientificdiscourseandbruisingonlinedebatewillcometoaheadnextweekwhenadviserst

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Amylyx's ALS drug launch starts strong. It could be trouble for FDA

          MollyFerguson/STATBehindthestellarcommerciallaunchofAmylyxPharmaceuticals’treatmentforALSliesanuncom